CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $74,198
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$74,198. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-03-20 | SEGALL JUDITH Vice President & Secretary | Other acquisition · Option to Purchase Common Shares | +50,000 | 50,000 | ||
| 2014-03-20 | STOLZ LESLEY A. EVP, Corporate Development | Other acquisition · Option to Purchase Common Shares | +50,000 | 50,000 | ||
| 2014-03-20 | TEW WILLIAM P PHD Chief Commercial Officer | Other acquisition · Option to Purchase Common Shares | +100,000 | 100,000 | ||
| 2014-02-25 | BROADWOOD PARTNERS LP Director | Purchase | +500,000 | $3.74 | $1.9M | 9,822,262 |
| 2014-02-25 | BROADWOOD PARTNERS LP Director | Purchase | +0 | 9,822,262 | ||
| 2014-01-06 | Peabody Robert Sr. VP, COO, and CFO | Exercise or conversion | +25,000 | $0.50 | $13K | 30,400 |
| 2014-01-06 | Peabody Robert Sr. VP, COO, and CFO | Exercise or conversion · Option to Purchase Common Shares | −25,000 | 475,000 | ||
| 2013-12-30 | BRADSHER NEAL C Director | Purchase | +175,000 | $3.49 | $611K | 9,322,262 |
| 2013-12-30 | BRADSHER NEAL C Director | Purchase | +0 | 9,322,262 | ||
| 2013-12-27 | BRADSHER NEAL C Director | Purchase | +56,000 | $3.53 | $198K | 9,147,262 |
| 2013-12-27 | BRADSHER NEAL C Director | Purchase | +0 | 9,147,262 | ||
| 2013-12-26 | BRADSHER NEAL C Director | Purchase | +69,042 | $3.53 | $244K | 9,091,262 |
| 2013-12-26 | BRADSHER NEAL C Director | Purchase | +0 | 9,091,262 | ||
| 2013-11-20 | TEW WILLIAM P PHD Chief Commercial Officer | Sale | −3,860 | $3.73 | $14K | 33,265 |
| 2013-11-18 | TEW WILLIAM P PHD Chief Commercial Officer | Sale | −5,000 | $3.77 | $19K | 42,125 |
| 2013-11-18 | TEW WILLIAM P PHD Chief Commercial Officer | Sale | −5,000 | $3.76 | $19K | 37,125 |
| 2013-09-12 | FARRELL STEPHEN C Director | Purchase | +2,922 | $3.86 | $11K | 15,400 |
| 2013-09-11 | FARRELL STEPHEN C Director | Purchase | +8,291 | $3.90 | $32K | 12,478 |
| 2013-08-20 | BERGER FRANKLIN M Director | Purchase | +500 | $3.71 | $2K | 500 |
| 2013-08-20 | FARRELL STEPHEN C Director | Purchase | +2,700 | $3.66 | $10K | 4,187 |
Page 22 of 24 · 472 trades